Zevra Therapeutics, Inc. ZVRA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $37.89M+1,323% | $12.17M+134% | -$544K+98.4% | $74.71M+475% | -$3.1M+81.4% | ||
| $368K-77.7% | $362K-78.0% | $392K-75.8% | $1.65M+5.7% | $1.65M+5.6% | ||
| $3.11M-0.3% | $4.28M+6.6% | $2.77M-54.8% | $2.46M-6.4% | $3.12M+47.0% | ||
| $6.14M+175% | —— | —— | -$3.6M+81.2% | -$8.22M+49.1% | ||
| $35K-64.6% | $0— | $554K— | $213K— | $99K— | ||
| $79.62M+655% | $227K+104% | —— | $11.93M+9,351% | $10.54M-28.7% | ||
| $60.09M— | $0— | $0— | $0-100% | $0— | ||
| -$52.8M-3,386% | $2.55M+220% | $6.53M-89.9% | $1.38M-91.0% | $1.61M+32.0% | ||
| $33.19M+834% | $7.97M+139% | $6.73M-54.5% | $10.37M+389% | $3.56M+1,877% | ||
| $6.11M+173% | —— | —— | -$3.81M+80.0% | -$8.32M+48.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Zevra Therapeutics, Inc. generate?
- Zevra Therapeutics, Inc. (ZVRA) generated -$21.9M in operating cash flow over the trailing twelve months.
- What is Zevra Therapeutics, Inc.'s free cash flow?
- After $802.0K of capital expenditures, Zevra Therapeutics, Inc.'s free cash flow was -$22.3M over the trailing twelve months, up 68.0% year over year.
- Where does Zevra Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Zevra Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
